Associations of Prediabetes, Diabetes and Glucose‐Related Markers With Cognition and Neuroimaging in a 2‐Year Multidomain Lifestyle Randomised Controlled Trial
Diabetes/Metabolism Research and Reviews · 2025
DOI: 10.1002/dmrr.70053 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2025. Verfasst von Thais Lorenzo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimaging Research Group, BarcelonaBeta Brain Research Centre, Barcelona, Spain. Hauptthemen laut MEDLINE: Biomarkers, Cognition, Cognitive Dysfunction, Diabetes Mellitus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, EU Joint Programme - Neurodegenerative Disease Research JPND Multi-MeMo grant (Research Council of Finland), EU Innovative Health Initiative Joint Undertaking IHI JU AD-RIDDLE.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Few longitudinal studies have explored Oral Glucose Tolerance Test markers (OGTT) and both cognitive and brain changes. We investigated OGTT and other glycaemia and insulin resistance markers, and cognitive and neuroimaging changes in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER). Materials and Methods At‐risk individuals aged 60–77 years without dementia ( N = 1259) were randomly enrolled in a 2‐year multidomain lifestyle intervention or regular health advice program. 1025 participants without previously diagnosed diabetes underwent OGTT. Brain MRI scans were available for 132 participants and amyloid (PiB)‐PET and FDG‐PET scans for 47. Cognition was assessed using the modified Neuropsychological Test Battery (mNTB).
Results
Higher baseline dysglycaemia measures, particularly those from the OGTT, were connected to less favourable changes in multiple cognitive measures and hippocampal volume. Higher baseline triglyceride‐glucose (TyG) index was associated with higher amyloid accumulation and decline in brain glucose metabolism. Higher baseline glycated haemoglobin (HbA1c) was related to favourable changes in processing speed and cortical thickness. There were no significant intervention‐control differences in the change in glycaemia markers. Baseline dysglycaemia and glycaemia‐related markers did not modify the previously reported intervention benefits on cognition.
Conclusions
Higher baseline dysglycaemia measures are linked to more deleterious changes in cognition. Specifically, OGTT measures may be the most sensitive for detecting subtle glycaemic abnormalities associated with both unfavourable cognitive and neuroimaging changes. However, HbA1c shows mixed associations with cognition and neuroimaging in people at risk of dementia without previously diagnosed diabetes. This study emphasises the importance of more accurate glucose‐related markers when investigating early stages of glucose metabolism abnormalities and their relationship to subtle cognitive impairment and its structural brain correlates. Trial Registration ID NCT01041989 https://clinicaltrials.gov
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroimaging Research Group, BarcelonaBeta Brain Research Centre, Barcelona, Spain.
- Division of Clinical Geriatrics, Center for Alzheimer Research, NVS, Karolinska Institutet, Stockholm, Sweden.
- Neuroimaging of neurodegenerative Diseases and Healthy Aging, Neuroscience Research Program, Hospital Del Mar Research Institute, Barcelona, Spain.
- Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
- Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.
- Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
ORCID-Profile: Thais Lorenzo
Förderung
- Instituto de Salud Carlos III
- EU Joint Programme - Neurodegenerative Disease Research JPND Multi-MeMo grant (Research Council of Finland)
- EU Innovative Health Initiative Joint Undertaking IHI JU AD-RIDDLE
- European Research Council
- ERA PerMed Pattern-Cog grant
- Alzheimerfonden (Sweden)
- Region Stockholm
- Suomen Kulttuurirahasto
Zitieren
APA
Lorenzo, T., Ngandu, T., Lehtisalo, J., Antikainen, R., Gispert, J. D., Kemppainen, N., Laatikainen, T., Lindström, J., Rinne, J., Soininen, H., Strandberg, T., Torre, R., Tuomilehto, J., Solomon, A., & Kivipelto, M. (2025). Associations of Prediabetes, Diabetes and Glucose‐Related Markers With Cognition and Neuroimaging in a 2‐Year Multidomain Lifestyle Randomised Controlled Trial. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.70053
Vancouver
Lorenzo T, Ngandu T, Lehtisalo J, Antikainen R, Gispert JD, Kemppainen N, et al. Associations of Prediabetes, Diabetes and Glucose‐Related Markers With Cognition and Neuroimaging in a 2‐Year Multidomain Lifestyle Randomised Controlled Trial. Diabetes/Metabolism Research and Reviews. 2025. doi:10.1002/dmrr.70053
BibTeX
@article{Lorenzo2025,
author = {Lorenzo, Thais and Ngandu, Tiia and Lehtisalo, Jenni and Antikainen, Riitta and Gispert, Juan Domingo and Kemppainen, Nina and Laatikainen, Tiina and Lindström, Jaana and Rinne, Juha and Soininen, Hilkka and Strandberg, Timo and Torre, Rafael de la and Tuomilehto, Jaakko and Solomon, Alina and Kivipelto, Miia},
title = {Associations of Prediabetes, Diabetes and Glucose‐Related Markers With Cognition and Neuroimaging in a 2‐Year Multidomain Lifestyle Randomised Controlled Trial},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2025},
doi = {10.1002/dmrr.70053}
}
EUVIMED